PRF1 and neoplasm: First, CAR T cells eliminate tumor cells via direct cytotoxicity, which can be tested by the capability to degranulate (expression of CD107a), to produce cytotoxic molecules (i.e., granzyme B and perforin), and to induce cell death in target/tumor cells [32].